HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Chengalvala, M. V. Articles by Hung, P. P. Search for Related Content PubMed PubMed Citation Articles by Chengalvala, M. V. Articles by Hung, P. P. Agricola Articles by Chengalvala, M. V. Articles by Hung, P. P.

Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs

Biotechnology and Microbiology Division, Wyeth-Ayerst Research, P.O. Box 8299, Philadelphia, Pennsylvania 19101, U.S.A.

High yielding adenovirus (Ad)-hepatitis B recombinant (Ad-Hep B) viruses were prepared by insertion of the hepatitis B surface antigen (HBsAg) gene into the early region 3 (E3 region) of Ad4 or Ad7 vectors containing intact or largely deleted E3 regions. Both E3-deleted and non-deleted recombinants produced about six- to eight-fold higher amounts of HBsAg than previously reported recombinants. These recombinant viruses were evaluated for immunogenicity in dogs which sustain abortive lung infections by Ad4 and Ad7. Recombinants containing E3 deletions elicited 10- to 12-fold stronger anti-HBs primary responses than previously evaluated low yield recombinants. Further immunizations with heterotypic Ad-Hep B recombinants induced substantial anti-HBs booster responses as well as anti-‘a’ epitope responses. In contrast, recombinant viruses containing intact E3 regions induced only weak or negligible anti-HBs responses, although such viruses induced strong antibody responses to the Ad vectors. The immunogenicity of high-yielding Ad recombinants correlated with temporal expression of HBsAg and thus the dog represents a valuable model for evaluation of immune responses to heterologous proteins that are expressed early and that do not require efficient DNA replication. Recombinants expressing HBsAg late in the infectious cycle require further testing in the fully permissive chimpanzee model. This study establishes that the E3-deleted high yield Ad4 and Ad7 recombinants represent promising live oral hepatitis B vaccine candidates.

Received 24 May 1993; accepted 30 August 1993.

This article has been cited by other articles:

				S. C. Jacobs, A. J. Davison, S. Carr, A. M. Bennett, R. Phillpotts, and G. W. G. Wilkinson Characterization and manipulation of the human adenovirus 4 genome J. Gen. Virol., November 1, 2004; 85(11): 3361 - 3366. [Abstract] [Full Text] [PDF]

				A Sanz-Parra, B Vazquez, F Sobrino, S. Cox, V Ley, and J. Salt Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins J. Gen. Virol., March 1, 1999; 80(3): 671 - 679. [Abstract]